Pyrazolopyrimidines as therapeutic agents

US7332497B2 · kind B2 · utility

Assignee

• Abbott GmbH & Co. KG · DE

Inventors

• Gavin Hirst · Princeton, US
• Paul Rafferty · Nottingham, GB
• Kurt Ritter · Heidelberg, DE
• David J. Calderwood · Nottingham, GB
• Neil Wishart · Jefferson, US
• Lee D. Arnold · Rancho Santa Fe, US
• Michael Friedman · Jerusalem, IL

Key dates

• Filing date: Mar 22, 2002
• Grant date: Feb 19, 2008
• Expiry date: Mar 22, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides compounds of Formula I,including pharmaceutically acceptable salts and/or prodrugs thereof, where G, Ra, R2, and R3 are defined as described herein.